The Global Micro Computed Tomography market is expected to reach USD 318.35 million by 2030, at a CAGR of 8.1% from 2021 to 2030. Micro-computed tomography (micro-CT) is a non-destructive imaging technology that is used to generate 3D images of objects. It is a type of X-ray imaging that can be used to analyze a range of objects, including bones, teeth, roots, and small organisms. Technology has become increasingly popular as it offers detailed images of the internal structure of objects. The technology is commonly used in biological research and preclinical drug development.
The rising prevalence of chronic diseases and the increasing demand for quality healthcare are the key factors driving the growth of the global micro-computed tomography market. Furthermore, the increasing application of micro-CT in various industries such as automotive, aerospace, and consumer electronics is propelling the growth of the market. Additionally, the growing demand for 3D imaging technology in drug development is expected to propel the growth of the market during the forecast period.
The growing demand for miniaturization in the automotive and aerospace industries is also driving the growth of the market. Furthermore, the increasing research and development activities in the medical field are also contributing to the growth of the market.
Restraints of Micro Computed Tomography Market
The high cost of micro-CT scanners is a major restraint of the market.
The report provides a detailed analysis of the global micro-computed tomography market. It also covers the key trends, opportunities, and challenges impacting the growth of the market. It provides an analysis of Porter’s Five Forces model to understand the competitive landscape of the market. Furthermore, it provides a detailed analysis of the current and future market trends to determine the overall attractiveness of the market.
The report also profiles the key players operating in the global micro-computed tomography market. It provides an analysis of their financials, product portfolios, and recent developments. Some of the key players profiled in the report include Bruker Corporation, Canon Medical Systems Corporation, GE Healthcare, Hitachi, Ltd., Nikon Corporation, Olympus Corporation, PerkinElmer, Inc., Shimadzu Corporation, SkyScan (Bruker Corporation), and Thermo Fisher Scientific Inc.